MILANAPHARM

MilanaPharm is a privately held specialty pharmaceutical company built upon a proprietary drug delivery platform capable of delivering a large number of active compounds. The platform, TRI-726, can deliver actives from several hours to several days. MilanaPharm’s focus is on developing pharmaceutical products within the chronic wound management segment. We strive to improve patient quality of life and reduce opioid dependence and addiction with effective alternatives for healing and pain.